Skip to main content
×
Home
    • Aa
    • Aa

Do atypical features affect outcome in depressed outpatients treated with citalopram?

  • Jonathan W. Stewart (a1), Patrick J. McGrath (a1), Maurizio Fava (a2), Stephen R. Wisniewski (a3), Sidney Zisook (a4), Ian Cook (a5), Andrew A. Nierenberg (a2), Madhukar H. Trivedi (a6), G. K. Balasubramani (a3), Diane Warden (a6), Ira Lesser (a5) and A. John Rush (a7)...
Abstract
Abstract

Depressed patients with atypical features have an earlier onset of depression, a more chronic course of illness, several distinctive biological and familial features, and a different treatment response than those without atypical features. The efficacy and tolerability of selective serotonin reuptake inhibitors (SSRIs) have not been fully evaluated in depression with atypical features. This report evaluates data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study to determine whether depressed outpatients with and without atypical features respond differently to the SSRI citalopram. Treatment-seeking participants with non-psychotic major depressive disorder were recruited from primary- and psychiatric-care settings. The presence/absence of atypical features was approximated using baseline ratings on the 30-item Inventory of Depressive Symptomatology – Clinician-rated. Following baseline assessments, participants received citalopram up to 60 mg/d for up to 14 wk. Baseline sociodemographic and clinical characteristics, and treatment outcomes, were compared between participants with and without atypical features. Of the 2876 evaluable STAR*D participants, 541 (19%) had atypical features. Participants with atypical features were significantly more likely to be female, younger, unemployed, have greater physical impairment, a younger age of depression onset, a longer index episode, greater depressive severity, and more concurrent anxiety diagnoses. Those with atypical features had significantly lower remission rates, although this difference was no longer present after adjustment for baseline differences. Depressed patients with atypical features are less likely to remit with citalopram than those without atypical features. This finding is probably due to differences in baseline characteristics other than atypical symptom features.

Copyright
Corresponding author
Address for correspondence: J. W. Stewart, M.D., 1051 Riverside Drive, New York, NY10032, USA. Tel.: 212-543-5734Fax: 212-543-5326Email: jws6@columbia.edu
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

G Amori , RH Lenox (1989). Do volunteer subjects bias clinical trials? Journal of Clinical Psychopharmacology 9, 321327.

J Angst , A Gamma , F Benazzi , B Silverstein , VA Ajdacic-Gross , D Eich , W Rössler (2006). Atypical depressive syndromes in varying definitions. European Archives of Psychiatry and Clinical Neuroscience 257, 4454.

J Angst , A Gamma , R Sellaro , H Zhang , K Merikangas (2002). Toward validation of atypical depression in the community: results of the Zurich cohort study. Journal of Affective Disorders 72, 125138.

H Anisman , AV Ravindran , J Griffiths , Z Merali (1999). Endocrine and cytokine correlates of major depression and dysthymia with and without atypical features. Molecular Psychiatry 4, 182188.

F Benazzi (1999). Prevalence and clinical features of atypical depression in depressed outpatients: a 467-case study. Psychiatry Research 86, 259264.

F Benazzi (2002). Psychomotor changes in melancholic and atypical depression: unipolar and bipolar-II subtypes. Psychiatry Research 112, 211220.

RJ Bielski , RB Lydiard (1997). Therapeutic trial participants: where do we find them and what does it cost? Psychopharmacology Bulletin 33, 7578.

WA Brown , MF Johnson , MG Chen (1992). Clinical features of depressed patients who do and do not improve with placebo. Psychiatry Research 41, 203214.

PK Corey-Lisle , R Nash , P Stang (2004). Swindle R. Response, partial response, and nonresponse in primary care treatment of depression. Archives of Internal Medicine 164, 11971204.

JR Davidson , RD Miller , CD Turnbull , JL Sullivan (1982). Atypical depression. Archives of General Psychiatry 39, 527534.

M Fava , AJ Rush , MH Trivedi , AA Nierenberg , ME Thase , HA Sackeim , FM Quitkin , S Wisniewski , PW Lavori , JF Rosenbaum , DJ Kupfer (2003). Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatric Clinics of North America 26, 457494.

M Hamilton (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278296.

JM Himmelhoch , ME Thase , AG Mallinger , P Houck (1991). Tranylcypromine versus imipramine in anergic bipolar depression. American Journal of Psychiatry 148, 910916.

E Horwath , J Johnson , MM Weissman , CD Hornig (1992). The validity of major depression with atypical features based on a community study. Journal of Affective Disorders 26, 117126.

PR Joyce , RT Mulder , SE Luty , PF Sullivan , JM McKenzie , RM Abbott , IF Stevens (2002). Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Australian and New Zealand Journal of Psychiatry 36, 384391.

KS Kendler , LJ Eaves , EE Walters , MC Neale , AC Heath , RC Kessler (1996). The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Archives of General Psychiatry 53, 391399.

AY Khan , J Carrithers , SH Preskorn , R Lear , SR Wisniewski , AJ Rush , D Stegman , C Kelley , K Kreiner , AA Nierenberg , M Fava (2006). Clinical and demographic factors associated with DSM-IV melancholic depression. Annals of Clinical Psychiatry 18, 9198.

MR Liebowitz , FM Quitkin , JW Stewart , PJ McGrath , WM Harrison , JS Markowitz , JG Rabkin , E Tricamo , DM Goetz , DF Klein (1988). Antidepressant specificity in atypical depression. Archives of General Psychiatry 45, 129137.

BS Linn , MW Linn , L Gurel (1968). Cumulative Illness Rating Scale. Journal of the American Geriatric Society 16, 622626.

J Lonnqvist , S Sihvo , E Syvalahti , O Kiviruusu (1994). Moclobemide and fluoxetine in atypical depression: a double-blind trial. Journal of Affective Disorders 32, 169177.

LS Matza , DA Revicki , JR Davidson , JW Stewart (2003). Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Archives of General Psychiatry 60, 817826.

PJ McGrath , JW Stewart , MN Janal , E Petkova , FM Quitkin , DF Klein (2000). A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. American Journal of Psychiatry 157, 344350.

PJ McGrath , JW Stewart , FM Quitkin , Y Chen , JE Alpert , AA Nierenberg , M Fava , J Cheng , E Petkova (2006). Predictors of relapse in a prospective study of fluoxetine treatment of major depression. American Journal of Psychiatry 163, 15421548.

MD Miller , CF Paradis , PR Houck , S Mazumdar , JA Stack , AH Rifai , B Mulsant , CF Reynolds III (1992). Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Research 41, 237248.

JS Novick , JW Stewart , SR Wisniewski , IA Cook , R Manev , AA Nierenberg , JF Rosenbaum , K Shores-Wilson , GK Balasubramani , MM Biggs , S Zisook , AJ Rush ; STAR*D investigators (2005). Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. Journal of Clinical Psychiatry 66, 10021011.

AC Pande , M Birkett , S Fechner-Bates , RF Haskett , JF Greden (1996). Fluoxetine versus phenelzine in atypical depression. Biological Psychiatry 40, 10171020.

G Parker , I Blignault (1983). A comparative study of neurotic depression in symptomatic volunteers. Australia and New Zealand Journal of Psychiatry 17, 7481.

G Parker , K Roy , P Mitchell , K Wilhelm , G Malhi , D Hadzi-Pavlovic (2002). Atypical depression: a reappraisal. American Journal of Psychiatry 159, 14701479.

ES Paykel , JA Hollyman , P Freeling , P Sedgwick (1988). Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. Journal of Affective Disorders 14, 8395.

G Perugi , HS Akiskal , L Lattanzi , D Cecconi , C Mastrocinque , A Patronelli , S Vignoli , E Bemi (1998). The high prevalence of ‘soft’ bipolar (II) features in atypical depression. Comprehensive Psychiatry 39, 6371.

MA Posternak , M Zimmerman (2002). Partial validation of the atypical features subtype of major depressive disorder. Archives of General Psychiatry 59, 7076.

FM Quitkin , PJ McGrath , JW Stewart , W Harrison , E Tricamo , SG Wager , K Ocepek-Welikson , E Nunes , JG Rabkin , DF Klein (1990). Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. Archives of General Psychiatry 47, 935941.

JG Rabkin , JW Stewart , FM Quitkin , PJ McGrath , WM Harrison , DF Klein (1996). Should atypical depression be included in DSM-IV? In: TA Widiger , AJ Frances , HA Pincus , R Ross , MB First , WW Davis (Eds.), APA DSM-IV Source Book (pp. 239260). Washington, DC: American Psychiatric Association.

MH Rapaport , T Frevert , S Babior , S Seymour , S Zisook , J Kelsoe , LL Judd (1996). A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disorders. Journal of Clinical Psychopharmacology 16, 242246.

E Robins , SB Guze (1970). Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry 126, 983987.

AJ Rush , TJ Carmody , HM Ibrahim , MH Trivedi , MM Biggs , K Shores-Wilson , ML Crismon , MG Toprac , TM Kashner (2006). Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. Psychiatric Services 57, 829837.

AJ Rush , M Fava , SR Wisniewski , PW Lavori , MH Trivedi , HA Sackeim , ME Thase , AA Nierenberg , FM Quitkin , TM Kashner , : Sequenced Treatment Alternatives to Relieve Depression (STAR*D) (2004). Rationale and design. Controlled Clinical Trials 25, 118141.

AJ Rush , DE Giles , MA Schlesser , CL Fulton , J Weissenburger , C Burns (1986). The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Research 18, 6587.

AJ Rush , MH Trivedi , HM Ibrahim , TJ Carmody , B Arnow , DN Klein , JC Markowitz , PT Ninan , S Kornstein , R Manber , (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry 54, 573585.

D Smith , C Dempster , J Glanville , N Freemantle , I Anderson (2002). Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. British Journal of Psychiatry 180, 396404.

J Søgaard , R Lane , P Latimer , K Behnke , PE Christiansen , B Nielsen , AV Ravindran , RT Reesal , DP Goodwin (1999). A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression. Journal of Psychopharmacology 13, 406414.

JW Stewart , PJ McGrath , FM Quitkin , DF Klein (2007). Atypical depression: Current status and relevance to melancholia. Acta Psychiatrica Scandanavia 115 (Suppl. 433), 5871.

JW Stewart , PJ McGrath , FM Quitkin , DF Klein (in press). DSM-IV depression with atypical features: is it valid? Neuropsychopharmacology.

JW Stewart , FM Quitkin , MR Liebowitz , PJ McGrath , WM Harrison , DF Klein (1983). Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness. Archives of General Psychiatry 40, 202207.

JW Stewart , FM Quitkin , PJ McGrath , J Amsterdam , M Fava , J Fawcett , F Reimherr , J Rosenbaum , C Beasley , P Roback (1998). Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. Archives of General Psychiatry 55, 334343.

P Stratta , F Bolino , M Cupillari , M Casacchia (1991). A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression. International Clinical Psychopharmacology 6, 193196.

PF Sullivan , RC Kessler , KS Kendler (1998). Latent class analysis of lifetime depressive symptoms in the National Comorbidity Survey. American Journal of Psychiatry 155, 13981406.

J Tedlow , M Fava , L Uebelacker , AA Nierenberg , JE Alpert , J Rosenbaum (1998). Outcome definitions and predictors in depression. Psychotherapy & Psychosomatics 67, 266270.

ME Thase , AR Entsuah , RL Rudolph (2001). Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. British Journal of Psychiatry 178, 234241.

ME Thase , CG Last , M Hersen , AS Bellack , JM Himmelhoch (1984). Symptomatic volunteers in depression research: a closer look. Psychiatry Research 11, 2533.

MH Trivedi , AJ Rush , HM Ibrahim , TJ Carmody , MM Biggs , T Suppes , ML Crismon , K Shores-Wilson , MG Toprac , EB Dennehy , B Witte , TM Kashner (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychological Medicine 34, 7382.

MH Trivedi , AJ Rush , SR Wisniewski , AA Nierenberg , D Warden , L Ritz , G Norquist , RH Howland , B Lebowitz , PJ McGrath , ; STAR*D Study Team (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry 163, 2840.

SR Wisniewski , AJ Rush , GK Balasubramani , MH Trivedi , AA Nierenberg (2006). Self-rated global measure of the frequency, intensity, and burden of side effects. Journal of Psychiatric Practice 12, 7179.

M Zimmerman , I Chelminski , MA Posternak (2005). Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. American Journal of Psychiatry 162, 13701372.

M Zimmerman , JI Mattia (2001 a). A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Archives of General Psychiatry 58, 787794.

M Zimmerman , JI Mattia (2001 b). The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Comprehensive Psychiatry 42, 175189.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The International Journal of Neuropsychopharmacology
  • ISSN: 1461-1457
  • EISSN: 1469-5111
  • URL: /core/journals/the-international-journal-of-neuropsychopharmacology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: